US$ 27.86
glp 1 agonist medullary thyroid cancer Frontiers Do GLP-1 Medications Cause Thyroid
Description
doi: 10.1186/s12933-016-0371-z

doi: 10.1007/s11481-021-10022-7
Int J Cardiol (2017) 240:41421

As a GLP-1 receptor agonist, it regulates appetite and improves blood sugar control, making it suitable for those with obesity or related health issues

Priorities for future research include sustaining long-term weight loss, establishing disease-modifying potential in nonmetabolic disorders, and addressing health equity concerns to ensure broader global benefit

Glucagon-Like Peptide-1 Receptor Is Involved in Learning and Neuroprotection
